Sundar JS, Srijayanth P, Karthikeyan PR, Hemapriya AS, Valarmathi S, Kalpana S, et al. Risk factors for cervical cancer among women reporting government tertiary care hospitals in Chennai, Tamil Nadu, Southern India: a cross-sectional study. Int J Res Med Sci. 2020;12(12):4611–6.

Article  Google Scholar 

Arbyn M, Weiderpass E, Bruni L, De Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-203.

Article  PubMed  Google Scholar 

Tamilarasi R, Maheshwari L, Siddharth R. A study of awareness on cervical cancer and prevalence of pathological leucorrhoea among women in rural Chennai. Int J Community Med Public Health. 2018;5(5):2118.

Article  Google Scholar 

Singh M, Jha RP, Shri N, Bhattacharyya K, Patel P, Dhamnetiya D. Secular trends in incidence and mortality of cervical cancer in India and its states, 1990–2019: data from the global burden of disease 2019 study. BMC Cancer. 2022;22(1):149.

Article  PubMed  PubMed Central  Google Scholar 

Wang LN, Wang F, Liu J, Jin YH, Fang C, Ren XQ. CYP1A1 Ile462Val polymorphism is associated with cervical cancer risk in caucasians not Asians: a meta-analysis. Front Physiol. 2017;18(8):1081.

Article  Google Scholar 

Kiruthiga P, Kannan MR, Saraswathi C, Pandian SK, Pandima K. CYP1A1 gene polymorphisms: lack of association with breast cancer susceptibility in the southern region (Madurai) of India. Asian Pac J Cancer Prev. 2011;12:2133.

PubMed  CAS  Google Scholar 

Ahangar N. Frequency evaluation of T6235C (m1) and A4889G (m2) polymorphisms of CYP1A1 gene in a healthy population from the west of mazandaran province. Iran Cell Mol Biol. 2016;62(7):90.

PubMed  CAS  Google Scholar 

Bag A, Jyala N, Bag N. Cytochrome P450 1A1 genetic polymorphisms as cancer biomarkers. Indian J Cancer. 2015;52(4):479.

Article  PubMed  CAS  Google Scholar 

Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection. Gynecol Oncol. 2006;101(3):411–7.

Article  PubMed  CAS  Google Scholar 

Gutman G, Morad T, Peleg B, Peretz C, Bar-Am A, Safra T, et al. CYP1A1 and CYP2D6 Gene Polymorphisms in Israeli Jewish Women With Cervical Cancer. Int J Gynecol Cancer. 2009;19(8):1300–2.

Article  PubMed  Google Scholar 

Taskiran C, Aktas D, Yigit-Celik N, Alikasifoglu M, Yuce K, Tunçbilek E, et al. CYP1A1 gene polymorphism as a risk factor for cervical intraepithelial neoplasia and invasive cervical cancer. Gynecol Oncol. 2006;101(3):503–6.

Article  PubMed  CAS  Google Scholar 

Abbas M, Srivastava K, Imran M, Banerjee M. Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population. Eur J Obstet Gynecol Reprod Biol. 2014;176:68–74.

Article  PubMed  CAS  Google Scholar 

Barek MdA, Basher MA, Aziz MdA, Hossen MdS, Jahan N, Afroz N, et al. Assessment of the association of CYP1A1 gene polymorphisms with the susceptibility of cervical cancer: A case-control study and meta-analysis. Heliyon. 2023;9(7):e17712.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, et al. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer. 2008;112(9):1964–73.

Article  PubMed  CAS  Google Scholar 

Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res Toxicol Environ Mutagen. 2000;464(1):65–76.

Article  CAS  Google Scholar 

Jain V, Ratre YK, Amle D, Mishra PK, Patra PK. Polymorphism of CYP1A1 gene variants rs4646903 and rs1048943 relation to the incidence of cervical cancer in Chhattisgarh. Environ Toxicol Pharmacol. 2017;52:188–92.

Article  PubMed  CAS  Google Scholar 

Datkhile KD, Patil SR, Patil MN, Durgawale PP, Jagdale NJ, Deshmukh VN, et al. Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: findings from a hospital-based case-control study. J Cancer Res Ther. 2023;19(7):1925–30.

Article  PubMed  CAS  Google Scholar 

Helaoui A, Sfar S, Boudhiba N, Dehghanian F, Dehbashi M, Bouchahda H, et al. Association of xenobiotic-metabolizing genes polymorphisms with cervical cancer risk in the Tunisian population. Mol Biol Rep. 2023;50(2):949–59.

Article  PubMed  CAS  Google Scholar 

Satinder K, Sobti RC, Pushpinder K. Impact 0f single nucleotide polymorphism in chemical metabolizing genes and exposure to wood smoke on risk of cervical cancer in North-Indian women. Exp Oncol. 2017;39(1):69–74.

Article  PubMed  CAS  Google Scholar 

Nath N, Mishra P, Panda AK, Mishra R. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India. Int Immunopharmacol. 2020;88:106925.

Article  PubMed  CAS  Google Scholar 

Sudenga SL, Shrestha S, Macaluso M, Partridge EE, Johanning GL, Piyathilake CJ. Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection. Gynecol Oncol. 2014;135(3):560–4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Xia L, Gao J, Liu Y, Wu K. Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis. Tumour Biol. 2013;34(1):223–30.

Article  PubMed  CAS  Google Scholar 

Matos A, Castelão C, Pereira Da Silva A, Alho I, Bicho M, Medeiros R, et al. Epistatic Interaction of CYP1A1 and COMT Polymorphisms in Cervical Cancer. Pallottini V, editor. Oxid Med Cell Longev. 2016; 2016(1):2769804.

Von Keyserling H, Bergmann T, Schuetz M, Schiller U, Stanke J, Hoffmann C, et al. Analysis of4 single-nucleotide polymorphisms in relation to cervical dysplasia and cancer development using a high-through put ligation-detection reaction procedure. Int J Gynecol Cancer. 2011;21(9):1664–71.

Article  Google Scholar 

Juárez-Cedillo T, Vallejo M, Fragoso JM, Hernández-Hernández DM, Rodríguez-Pérez JM, Sánchez-García S, et al. The risk of developing cervical cancer in Mexican women is associated to CYP1A1 MspI polymorphism. Eur J Cancer. 2007;43(10):1590–5.

Article  PubMed  Google Scholar 

Sugawara T, Nomura E, Sagawa T, Sakuragi N, Fujimoto S. CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer. 2003;13(6):785–90.

Article  PubMed  CAS  Google Scholar 

Li S, Li G, Kong F, Liu Z, Li N, Li Y, et al. The association of CYP 1A1 gene with cervical cancer and additional SNP – SNP interaction in Chinese women. J Clin Lab Anal. 2016;30(6):1220–5.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Das AP, Saini S, Agarwal SM. A comprehensive meta-analysis of non-coding polymorphisms associated with precancerous lesions and cervical cancer. Genomics. 2022;114(3):110323.

Article  PubMed  CAS  Google Scholar 

Sengupta D, Guha U, Mitra S, Ghosh S, Bhattacharjee S, Sengupta M. Meta-Analysis of polymorphic variants conferring genetic risk to cervical cancer in Indian women supports CYP1A1 as an important associated locus. Asian Pac J Cancer Prev. 2018 [cited 2025 Jun 26];19(8). Available from: https://doi.org/10.22034/APJCP.2018.19.8.2071

Yang S, Jia C, Zhu H, Han S. CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a meta-analysis. Tumor Biol. 2012;33(6):2265–72.

Article  CAS  Google Scholar 

Wang S, Sun H, Jia Y, Tang F, Zhou H, Li X, et al. Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis. BMC Med Genet. 2015;16(1):25.

Article  PubMed  PubMed Central  Google Scholar 

Ding B, Sun W, Han S, Cai Y, Ren M, Shen Y. Cytochrome P450 1A1 gene polymorphisms and cervical cancer risk: a systematic review and meta-analysis. Medicine (Baltimore). 2018;97(13):e0210.

Article  PubMed  PubMed Central  CAS  Google Scholar 

He XF, Wei W, Liu ZZ, Shen XL, Yang XB, Wang SL, et al. Association between the CYP1A1 T3801C polymorphism and risk of cancer: evidence from 268 case–control studies. Gene. 2014;534(2):324–44.

Article